Abstract:Objective Defects in the insulin receptor ( INSR ) gene cause various severe insulin resistance conditions, including Donohue syndrome (DS), Rabson-Mendenhall syndrome (RMS) and type A insulin resistance (type A-IR). This study aimed to investigate the clinical characterization and molecular defects in three Chinese children with INSR -related insulin resistance syndrome. Methods We reviewed the clinical data of three Chinese children with INSR -related insulin resistance syndrome from two unrelated kindreds. Genetic analysis was performed using whole-exome sequencing and the effects of the novel variants were further assessed by in vitro functional assays. Results The proband with type A-IR presented with acanthosis nigricans, hypertrichosis, and euglycemia with mild insulin resistance in early childhood. His sister presented with features typical of type A-IR and was diagnosed with diabetes mellitus with severe insulin resistance at the age of 9.8 years. The proband with DS showed typical dysmorphic characteristics, severe intrauterine growth retardation, extreme insulin resistance, fasting hypoglycemia and postprandial hyperglycemia from birth. The heterozygote variants c.[3670G>A]; c.[3614C>T] were identified in both siblings with type A-IR; and c.[749_751del]; c.[3355C>T] in the patient with DS. In vitro studies showed that the novel variant c.749_751del [p.(Thr250del)] in the α-subunit, reduced expression of the mature INSR protein and severely impaired INSR function. In contrast, the novel variant c.3670G>A [p.(Val1224Met)] in the β-subunit had no effect on total protein expression and phosphorylation of INSR and Akt, suggesting that the variant p.Val1224Met appeared to be tolerated and was not responsible for the severe insulin resistance. Conclusion Our study detailed the clinical features of three patients with type A-IR and DS, and identified two novel variants in the INSR gene. Functional assays indicated the novel variant p.Thr250del was pathogenic. In contrast, the novel variant p.Val1224Met was suggested to be tolerated by our experimental data, even though bioinformatics analyses predicted the variant as deleterious.

Deep mutational scanning of the human insulin receptor ectodomain to inform precision therapy for insulin resistance

Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy

Using site-directed mutagenesis to further the understanding of insulin receptor-insulin like growth factor-1 receptor heterodimer structure

Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome

Transcriptional Regulation of INSR, the Insulin Receptor Gene

Tuning Insulin Receptor Signaling Using De Novo Designed Agonists

Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations

Structure-Based Computational Analysis of Interactions between Insulin Receptor and Insulin Inhibitory Receptor

functional profiling and structural characterisation of the human A316T variant

Identification of a novel mutation in patients with type A insulin resistance syndrome

Identification and functional assessment of novel and known insulin receptor mutations in five patients with syndromes of severe insulin resistance

High-throughput Functional Dissection of Noncoding SNPs with Biased Allelic Enhancer Activity for Insulin Resistance-Relevant Phenotypes

How Insulin Binds to the Insulin Receptor: A Synthetic Chemical Biology Approach

Structural Resolution Of A Tandem Hormone-Binding Element In The Insulin Receptor And Its Implications For Design Of Peptide Agonists

Insulin-induced conformational changes in the full-length insulin receptor: structural insights gained from molecular modeling analyses

Diverse Intracellular Trafficking of Insulin Analogs by Machine Learning-based Colocalization and Diffusion Analysis

Activation of the insulin receptor by an insulin mimetic peptide

Insulin regulates human pancreatic endocrine cell differentiation in vitro

Development of a Novel GLUT4 Translocation Assay for Identifying Potential Novel Therapeutic Targets for Insulin Sensitization.

A novel heterozygous mutation in the insulin receptor gene presenting with type A severe insulin resistance syndrome

Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes